Erratum: Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: A retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (Bone Marrow Transplantation (2013) 48 (1513-1518) DOI: 10.1038/bmt.2013.140));Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: A retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation

Bone Marrow Transplantation

Volumn 48, Issue 12, 2013, Pages 1513-1518

  Kanamori, H ^a   Mizuta, S ^b   Kako, S ^c   Kato, H ^d   Nishiwaki, S ^e   Imai, K ^f   Shigematsu, A ^g   Nakamae, H ^h   Tanaka, M ^a   Ikegame, K ⁱ   Yujiri, T ^j   Fukuda, T ^k   Minagawa, K ^l   Eto, T ^m   Nagamura Inoue, T ⁿ   Morishima, Y ^d   Suzuki, R ^e   Sakamaki, H ^o   Tanaka, J ^p  

^a KANAGAWA CANCER CENTER   (Japan)

^b FUJITA HEALTH UNIVERSITY HOSPITAL   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f SAPPORO HOKUYU HOSPITAL   (Japan)

^g HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ HYOGO COLLEGE OF MEDICINE   (Japan)

^j YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k NATIONAL CANCER CENTER HOSPITAL   (Japan)

^l KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^m HAMANOMACHI HOSPITAL   (Japan)

ⁿ UNIVERSITY OF TOKYO   (Japan)

^o TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^p TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

ALL; elderly; reduced intensity SCT

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; LYMPHOCYTE ANTIBODY; MELPHALAN; PROTEIN TYROSINE KINASE INHIBITOR; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGE DISTRIBUTION; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; B CELL LEUKEMIA; CANCER MORTALITY; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; ENGRAFTMENT; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; JAPAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHILADELPHIA 1 CHROMOSOME; PREDICTION; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; SURVIVAL RATE; T CELL DEPLETION; TREATMENT OUTCOME; UNRELATED DONORS; WHOLE BODY RADIATION;

AGE FACTORS; AGED; B-LYMPHOCYTES; COHORT STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VIDARABINE;

EID: 84889606772     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.179     Document Type: Erratum

References (20)

1. Kantarjian HM, O'Brien S, Smith TL, Cortes J, Giles FJ, Beran M et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 2000; 18: 547-561 (Pubitemid 30078536)
2. Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and leukemia group B study 8811. Blood 1995; 85: 2025-2037
3. Rowe JM, Buck G, Burnett AK, Chopra R, Wiernik PH, Richards SM et al. Induction therapy for adults with acute lymphoblastic leukemia: Results of more than 1500 patients from the international ALL trial: MRC UKALLXII/ECOG E2993. Blood 2005; 106: 3760-3767 (Pubitemid 41739010)
4. Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: Final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008; 111: 1827-1833 (Pubitemid 351451489)
5. Arnold R, Massenkeil G, Bornhäuser M, Ehninger G, Beelen DW, Fauser AA et al. Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease. Leukemia 2002; 16: 2423-2428 (Pubitemid 36054377)
6. Martino R, Giralt S, Caballero MD, Mackinnon S, Corradini P, Fernández-Avilés F et al. Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: A feasibility study. Haematologica 2003; 88: 555-560 (Pubitemid 36648445)
7. Mohty M, Labopin M, Tabrizzi R, Theorin N, Fauser AA, Rambaldi A et al. Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: A retrospective study from the European Group for Blood and Marrow Transplantation. Haematologica 2008; 93: 303-306 (Pubitemid 351409331)
8. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828
9. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250-259
10. Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M et al. Reduced intensity conditioning regimen workshop: Defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 2009; 15: 367-369
11. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-1154
12. Fine JP, Gray RJ. A propotional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509
13. Kanda Y. Investigation of the freely-Available easy-To-use software 'EZR (Easy R) for medical statistics. Bone Marrow Transplant 2013; 48: 452-458
14. Marks DI, Wang T, Pérez WS, Antin JH, Copelan E, Gale RP et al. The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission. Blood 2010; 116: 366-374
15. Mohty M, Labopin M, Volin L, Gratwohl A, Socié G, Esteve J et al. Reducedintensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: A retrospective study from the European Group for Blood and Marrow Transplantation. Blood 2010; 116: 4439-4443
16. Cho BS, Lee S, Kim YJ, Chung NG, Eom KS, Kim HJ et al. Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: Result of a prospective phase 2 study. Leukemia 2009; 23: 1763-1770
17. Rowe JM. Prognostic factors in adult acute lymphoblastic leukaemia. Br J Haematol 2010; 150: 389-405
18. Faderl S, Jeha S, Kantarjian HM. The biology and therapy of adult acute lymphoblastic leukemia. Cancer 2003; 98: 1337-1354 (Pubitemid 37151487)
19. Yanada M, Takeuchi J, Sugiura I, Akiyama H, Usui N, Yagasaki F et al. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: A phase II study by the Japan Adult Leukemia Study Group. J Clin Oncol 2006; 24: 460-466 (Pubitemid 46630465)
20. Bachanova V, Verneris MR, DeFor T, Brunstein CG, Weisdorf DJ, Vermeris MR. Prolonged survival in adults with acute lymphoblastic leukemia after reducedintensity conditioning with cord blood or sibling donor transplantation. Blood 2009; 113: 2902-2905